Cardiovascular Systems, Inc. (CSII) News
Filter CSII News Items
CSII News Results
Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
---|---|---|---|---|---|---|---|---|---|
Loading, please wait... |
CSII News Highlights
- CSII's 30 day story count now stands at 3.
- Over the past 20 days, the trend for CSII's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
Latest CSII News From Around the Web
Below are the latest news stories about CARDIOVASCULAR SYSTEMS INC that investors may wish to consider to help them evaluate CSII as an investment opportunity.
Cytek Biosciences Set to Join S&P SmallCap 600Cytek Biosciences Inc (NASD:CTKB) will replace Cardiovascular Systems Inc. (NASD:CSII) in the S&P SmallCap 600 effective prior to the opening of trading on Monday, May 1. S&P 500 and 100 constituent Abbott Laboratories (NYSE:ABT) is acquiring Cardiovascular Systems in a deal expected to be completed soon, pending final closing conditions. |
Cardiovascular Systems, Inc.'s (NASDAQ:CSII) Subdued P/S Might Signal An OpportunityIt's not a stretch to say that Cardiovascular Systems, Inc.'s ( NASDAQ:CSII ) price-to-sales (or "P/S") ratio of 3.5x... |
Cardiovascular Systems (CSII) Finishes ECLIPSE Trial EnrollmentCardiovascular Systems' (CSII) ECLIPSE clinical trial data is likely to help physicians form an optimal treatment plan for patients with severely calcified coronary arteries. |
Cardiovascular Systems, Inc. Completes Enrollment of ECLIPSE Clinical TrialST. PAUL, Minn., April 03, 2023--CARDIOVASCULAR SYSTEMS, INC. COMPLETES ENROLLMENT OF ECLIPSE CLINICAL TRIAL |
Why Is NuVasive (NUVA) Down 15.9% Since Last Earnings Report?NuVasive (NUVA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. |
Why Is Medtronic (MDT) Down 6.1% Since Last Earnings Report?Medtronic (MDT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. |
Cardiovascular Systems (CSII) Ails From Soft Volume, Macro WoesTough competition and consistent net loss continue to pose threats to Cardiovascular Systems (CSII). |
Here's Why We're Not Too Worried About Cardiovascular Systems' (NASDAQ:CSII) Cash Burn SituationEven when a business is losing money, it's possible for shareholders to make money if they buy a good business at the... |
Which Healthcare Stock Is a Better Pick in 2023?With a potential recession on the horizon, healthcare stocks could be good picks for investors. |
Abbott (ABT) to Expand Vascular Device Line With New BuyoutAbbott's (ABT) latest deal will help gain access to Cardiovascular System's leading atherectomy device to treat vascular disease. |